Clinical Trials Directory

Trials / Completed

CompletedNCT04250194

Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration

Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration, a Randomized Controlled Study (VERITAS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
288 (actual)
Sponsor
Vanderbilt-Ingram Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate which procedure is the best for patients referred for biopsy of a lung nodule (growth in the lung) meeting the size and location requirements of the protocol. Two different procedures are available for lung nodule biopsy: 1. a computed tomography guided biopsy ("CT-guided biopsy") which consists of sampling the nodule from the "outside-in", through the chest wall with CT guidance, and 2. navigation bronchoscopy, which is a procedure using technology designed to guide a catheter through the natural airway route (wind-pipe and bronchi) to access the nodule.

Detailed description

Endpoints: Primary: • To evaluate diagnostic accuracy through 12 months of clinical follow-up Secondary: * To evaluate rate of pneumothorax. * To evaluate rate of pneumothorax requiring chest tube placement. * To evaluate clinically significant bleeding (defined by bleeding requiring intervention). * To evaluate need for hospitalization after procedure. * To evaluate duration of the procedure. * To evaluate procedural factors associated with improved yield (type of biopsy, number of biopsies, use of radial ultrasound, presence of a bronchus sign, biopsy site). * To evaluate need for additional nodule biopsy. * To evaluate need for additional procedure for staging. * To evaluate radiation exposure from fluoroscopy-guided bronchoscopy and CT for CT-guided biopsy. * To evaluate need for F-Nav (digital tomosynthesis) during navigation bronchoscopy. * To evaluate diagnostic yield * To evaluate the rate at which the biopsy procedure yields a confident clinical diagnosis (including any added yield from endobronchial ultrasound-guided mediastinal and/or hilar lymph node biopsies or microbiologic studies which yield an explanation for a nodule despite non-diagnostic biopsy specimens).

Conditions

Interventions

TypeNameDescription
DEVICECT-Guided BiopsyImages will be generated by a CT scanner to accurately insert a needle into the lung nodule allowing a sample to be removed for testing
DEVICENavigation bronchoscopyA virtual three-dimensional map of the lung will be generated enabling the physician to perform an anatomically precise biopsy

Timeline

Start date
2020-05-22
Primary completion
2024-06-10
Completion
2024-07-02
First posted
2020-01-31
Last updated
2025-09-29
Results posted
2025-07-14

Locations

7 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04250194. Inclusion in this directory is not an endorsement.